Niccolo Giaj Levra
Overview
Explore the profile of Niccolo Giaj Levra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lancia A, Alitto A, Pappagallo G, Ciurlia E, Francolini G, DAngelillo R, et al.
Pract Radiat Oncol
. 2024 Nov;
PMID: 39490734
Purpose: Prostate cancer treatments paradigms are in continuous evolution, especially in the metastatic setting. In this context, the Genito-Urinary Group of Italian Association of Radiotherapy and Clinical Oncology aimed to...
2.
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort
Borghetti P, Facheris G, Ciammella P, Galaverni M, Granello L, Scotti V, et al.
Clin Lung Cancer
. 2023 Dec;
25(2):151-158.
PMID: 38052684
Aims: SCLC is the most aggressive lung cancer histology with a 5-year OS <10%. At the diagnosis, almost two-thirds of the SCLC an Extended Disease presentation. Two randomized studies (CASPIAN...
3.
Inno A, Marchetti F, Valerio M, Giaj Levra N, Alongi F, Foti G, et al.
Drug Target Insights
. 2023 Jul;
17:90-91.
PMID: 37408855
In the CodeBreaK 100 phase 2 study, sotorasib was active for patients with metastatic non-small cell lung cancer (NSCLC) harboring Kirsten rat sarcoma viral oncogene homologue (KRAS) p.G12C mutation. However,...
4.
Pastorello E, Nicosia L, Cuccia F, Olivari L, Fiorini M, Giaj Levra N, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345138
Background And Purpose: Stereotactic body radiotherapy (SBRT) has a consolidated role in the treatment of bone oligometastases from prostate cancer (PCa). While the evidence for spinal oligometastases SBRT was robust,...
5.
Cuccia F, Pastorello E, Vitale C, Figlia V, Giaj Levra N, Mazzola R, et al.
In Vivo
. 2023 Jan;
37(1):490-492.
PMID: 36593020
Background/aim: Sinonasal metastases arising from renal cell cancer are rare and usually managed with surgery. Few studies describe the use of radiotherapy in this specific setting, while the use of...
6.
Alongi F, Rigo M, Figlia V, Nicosia L, Mazzola R, Giaj Levra N, et al.
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556203
The present study reports the preliminary outcomes in terms of adverse events and quality of life in the first 100 patients treated with 1.5T MR-guided daily-adaptive stereotactic body radiotherapy for...
7.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, et al.
Tumori
. 2022 Sep;
108(2_suppl):1-144.
PMID: 36112842
Introduction: Breast cancer is the most common tumor in women and represents the leading cause of cancer death. Radiation therapy plays a key-role in the treatment of all breast cancer...
8.
Bruni A, Scotti V, Borghetti P, Vagge S, Cozzi S, DAngelo E, et al.
Front Oncol
. 2021 Dec;
11:802949.
PMID: 34869046
[This corrects the article DOI: 10.3389/fonc.2021.744956.].
9.
Bruni A, Scotti V, Borghetti P, Vagge S, Cozzi S, DAngelo E, et al.
Front Oncol
. 2021 Oct;
11:744956.
PMID: 34650927
Introduction: For unresectable stage III non-small cell lung cancer (NSCLC), the standard therapy consists of chemoradiotherapy (CRT) followed by durvalumab maintenance for responding patients. The present study reports on the...
10.
Buglione M, Guerini A, Filippi A, Spiazzi L, Pasinetti N, Magli A, et al.
Crit Rev Oncol Hematol
. 2021 Aug;
167:103437.
PMID: 34358649
Background: Secondary malignant neoplasms (SMNs) and cardiovascular diseases induced by chemotherapy and radiotherapy represent the main cause of excess mortality for early-stage Hodgkin lymphoma patients, especially when the mediastinum is...